Increased expression of RNF5 was observed in different malignancies including breast cancer, melanoma, hepatocellular carcinoma and acute myeloid leukemia (AML) where it correlated with poor prognosis and tumor progression [9,10,11]. Here, RNF5 is linked to breast carcinoma.